Home > Press release: Research Training Group for the further ...
Hosted on MSN2d
What's Happening — Feb. 13, 2025If you have an event you would like to have included, please email the information to Daily News Community Editor Max Milne at [email protected]. Thursday, Feb. 13 Chemical City Garden Club will ...
Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 ...
This review was published in The Tribune on 12th Jan. 2025] BOOK REVIEW- “ANANDA- AN EXPLORATION OF CANNABIS IN INDIA” by Karan Madhok.
It has been granted FDA orphan drug designation and European Commission orphan medicinal product designation. The upfront cash consideration in the transaction with Syncona is to consist of $0.34 ...
These drugs, discovered decades ago, continue to save lives today, but more recent research has led to the development of ...
In recent years, the conversation surrounding cannabis and its medicinal properties has gained considerable momentum.
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback